Global Pharmatech, Inc. (GBLP)

Global Pharmatech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Jan 22, 2026	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Market Capitalization	21	14	27	46	3	0
Market Cap Growth	155.15%	-48.85%	-40.22%	1433.42%	2933.28%	-
Enterprise Value	-	13	26	48	-	-
Last Close Price	0.05	0.60	1.17	2.50	0.90	0.80
PE Ratio	-	-	-	227.31	9.59	0.33
PS Ratio	6.53	4.95	12.81	14.79	1.91	0.06
PB Ratio	2.26	1.53	2.25	5.55	0.46	-
P/TBV Ratio	2.64	1.76	2.49	6.44	0.53	-
P/FCF Ratio	469.89	-	-	-	15.64	-
P/OCF Ratio	121.52	-	104.18	-	2.55	-
EV/Sales Ratio	-	4.46	12.08	15.66	-	-
EV/EBITDA Ratio	-	-	-	319.76	-	-
Debt / Equity Ratio	0.29	0.30	0.24	0.31	0.20	-
Debt / EBITDA Ratio	-	-	-	17.10	1.51	-
Debt / FCF Ratio	59.40	-	-	-	6.98	-
Asset Turnover	0.23	0.19	0.15	0.28	-	-
Inventory Turnover	1.59	1.26	0.40	1.30	-	-
Quick Ratio	1.61	1.70	5.30	1.74	0.32	-
Current Ratio	1.86	1.93	6.47	3.72	0.85	-
Return on Equity (ROE)	-22.59%	-23.53%	-8.87%	1.73%	-	-
Return on Assets (ROA)	-10.39%	-10.57%	-5.63%	-2.18%	-	-
Return on Invested Capital (ROIC)	-35.76%	-31.39%	-13.06%	-4.22%	5.70%	-
Return on Capital Employed (ROCE)	-25.10%	-27.30%	-8.70%	-3.50%	7.10%	-
Earnings Yield	-10.79%	-23.65%	-4.53%	0.44%	10.42%	304.63%
FCF Yield	0.21%	-4.11%	-0.56%	-4.88%	6.40%	-1411.38%
Buyback Yield / Dilution	-0.05%	-7.72%	-22.21%	-3.15%	-290.84%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.